换一批Biomodulation of capecitabine by paclitaxel and carboplatin in advanced solid tumors and adenocarcinoma of unknown primary.
第一作者：
Sameh,Mikhail
第一单位：
Richard Solove Research Institute, The Ohio State University Comprehensive Cancer Center-James Cancer Hospital, 320 W 10th Avenue, Columbus, OH, 43221, USA. sameh.mikhail@osumc.edu.
作者：
医学主题词
腺癌(Adenocarcinoma);成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卡铂(Carboplatin);无病生存(Disease-Free Survival);剂量效应关系, 药物(Dose-Response Relationship, Drug);用药计划表(Drug Administration Schedule);酶诱导(Enzyme Induction);食管肿瘤(Esophageal Neoplasms);疲劳(Fatigue);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);血液病(Hematologic Diseases);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);最大耐受剂量(Maximum Tolerated Dose);中年人(Middle Aged);肿瘤(Neoplasms);肿瘤, 未知原发灶(Neoplasms, Unknown Primary);紫杉酚(Paclitaxel);胰腺肿瘤(Pancreatic Neoplasms);药物前体(Prodrugs);胸苷磷酸化酶(Thymidine Phosphorylase);治疗结果(Treatment Outcome);增量调节(Up-Regulation);青年人(Young Adult)
DOI
10.1007/s00280-015-2877-6
PMID
26416564
发布时间
2015-10-21
- 浏览12
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
